Papadopoulos Angelos, Voniati Louiza, Ziavra Nafsika, Tafiadis Dionysios
School of Health Rehabilitation Sciences, University of Patras, 26500 Patras, Greece.
General Children's Hospital of Patras "Karamandaneio", 26331 Patras, Greece.
Brain Sci. 2024 Sep 19;14(9):937. doi: 10.3390/brainsci14090937.
This scoping review had as a primary goal a review of the literature and the an analysis of the possible effectiveness of the LSVT LOUD approach in children with voice and speech deficits.
A search was conducted in the Scopus and PubMed databases in May of 2024. Eleven articles were obtained from the search. The standards of PRISMA recommendations were used for scoping reviews and the PCC framework was used for the eligibility criteria. Furthermore, the study used the instructions in the Cochrane Handbook for a quality assessment. The Mendeley Reference Manager software collected the studies and removed duplicates.
The reviewed studies employed formal and informal measures to assess voice and speech abilities in the children. Regarding the sample's characteristics, the studies mostly included children with Cerebral Palsy (CP) and also those with Down Syndrome (DS). All the studies reported that children with CP and DS undertook a total dose of the LSVT LOUD treatment. Significant post-treatment findings indicated increased speech function and sound pressure level, regarding the auditory-perceptual ratings of voice and speech improvement. In many studies, parents' and expert listeners' ratings of voice, perception of vocal loudness, speech, and communication indicated improvement.
The majority of the included studies provide positive evidence for the LSVT as an approach. However, the small sample size that featured in the studies, as well as their limitations, made these conclusions uncertain. Moreover, the study's findings provided recommendations that speech language therapists and other clinicians need to follow when setting a treatment plan with children with CP and DS.
本综述性研究的主要目标是回顾文献,并分析LSVT LOUD方法对有语音和言语缺陷儿童的可能疗效。
2024年5月在Scopus和PubMed数据库中进行了检索。从检索中获得了11篇文章。采用PRISMA推荐标准进行综述性研究,并使用PCC框架制定纳入标准。此外,本研究采用了《Cochrane系统评价手册》中的指南进行质量评估。使用Mendeley参考文献管理软件收集研究并去除重复项。
纳入综述的研究采用正式和非正式的方法评估儿童的语音和言语能力。关于样本特征,这些研究大多纳入了患有脑瘫(CP)和唐氏综合征(DS)的儿童。所有研究均报告称,患有CP和DS的儿童接受了LSVT LOUD治疗的全剂量。治疗后的显著结果表明,在语音和言语改善的听觉感知评分方面,言语功能和声压水平有所提高。在许多研究中,家长和专业听众对语音、响度感知、言语和沟通的评分显示有所改善。
大多数纳入研究为LSVT方法提供了积极证据。然而,研究中的样本量较小及其局限性使得这些结论具有不确定性。此外,研究结果为言语治疗师和其他临床医生在为患有CP和DS的儿童制定治疗计划时提供了建议。